Literature DB >> 2537371

Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors.

H Wachtel1.   

Abstract

It is suggested that affective disorders arise from the dysbalance of the two major intraneuronal signal amplification systems, the adenylate cyclase and the phospholipase C system, with depression resulting from underfunction of cyclic adenosine 3',5'-monophosphate-mediated effector cell responses associated with an absolute or relative dominance of the inositoltriphosphate/diacylglycerol-mediated responses and mania resulting from the converse. The usefulness of this hypothesis is discussed with respect to (a) the mechanism of action of current therapeutic agents and (b) the development of novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2537371     DOI: 10.1007/bf01250641

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  36 in total

1.  Affective and atopic disorders and cyclic AMP.

Authors:  H J Ossofsky
Journal:  Compr Psychiatry       Date:  1976 Mar-Apr       Impact factor: 3.735

Review 2.  Phosphorylation-dephosphorylation of enzymes.

Authors:  E G Krebs; J A Beavo
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

3.  Beta-adrenergic receptor function in affective illness.

Authors:  G N Pandey; M W Dysken; D L Garver; J M Davis
Journal:  Am J Psychiatry       Date:  1979-05       Impact factor: 18.112

Review 4.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

Review 5.  Mechanisms in the vectorial receptor-adenylate cyclase signal transduction.

Authors:  J Codina; J Hildebrandt; T Sunyer; R D Sekura; C R Manclark; R Iyengar; L Birnbaumer
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

6.  General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.

Authors:  S J Strada; M W Martin; W J Thompson
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

7.  Lithium at therapeutic concentrations inhibits human brain noradrenaline-sensitive cyclic AMP accumulation.

Authors:  M Newman; E Klein; B Birmaher; M Feinsod; R H Belmaker
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

8.  Fluoride-stimulated adenylate cyclase activity in rat brain following chronic treatment with psychotropic drugs.

Authors:  P H Andersen; R Klysner; A Geisler
Journal:  Neuropharmacology       Date:  1984-04       Impact factor: 5.250

9.  Changes in lymphocyte beta-adrenergic receptors in depression and mania.

Authors:  I Extein; J Tallman; C C Smith; F K Goodwin
Journal:  Psychiatry Res       Date:  1979-10       Impact factor: 3.222

10.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Authors:  L M Hallcher; W R Sherman
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

View more
  9 in total

1.  Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase.

Authors:  R Schmiechen; H H Schneider; H Wachtel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.

Authors:  Ankur Jindal; Radhakrishnan Mahesh; Shvetank Bhatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

3.  [On a new pharmacological action of antidepressants].

Authors:  M Bourin
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

4.  The effect of acute and chronic lithium on forskolin-induced reduction of rat activity.

Authors:  Y Bersudsky; Y Patishi; J Bitsch Jensen; A Mørk; O Kofman; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  A preliminary study of possible psychoactive effects of intravenous forskolin in depressed and schizophrenic patients. Short communication.

Authors:  Y Bersudsky; M Kotler; M Shifrin; R H Belmaker
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  D1 dopamine receptor binding in mood disorders measured by positron emission tomography.

Authors:  T Suhara; K Nakayama; O Inoue; H Fukuda; M Shimizu; A Mori; Y Tateno
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Imbalance of the Gs and Gi/o function in post-mortem human brain of depressed patients.

Authors:  H Ozawa; W Gsell; L Frölich; R Zöchling; F Pantucek; H Beckmann; P Riederer
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  [3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study.

Authors:  B Arranz; J Marcusson
Journal:  J Neural Transm Gen Sect       Date:  1994

9.  The effects of gestational and lactational exposure to Nonylphenol on c-jun, and c-fos expression and learning and memory in hippocampus of male F1 rat.

Authors:  Yu Jie; Wang Pan; Yan Wenxia; Gao Feng; He Liting; Li Wenmei; Xu Jie
Journal:  Iran J Basic Med Sci       Date:  2017-04       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.